Search
Library
Log in
Watch fullscreen
5 months ago

FDA Will Review Johnson & Johnson Vaccine

Newsy
Newsy
Johnson & Johnson said its COVID vaccine candidate was 72% effective in a late stage trial.

Browse more videos

Browse more videos